Monitoring of Hematological and Hemostatic Parameters in Neurocritical Care Patients

The Participants in the International Multidisciplinary Consensus Conference on Multimodality Monitoring

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Anemia and bleeding are paramount concerns in neurocritical care and often relate to the severity of intracranial hemorrhage. Anemia is generally associated with worse outcomes, and efforts to minimize anemia through reduced volume of blood sampled are encouraged. Point-of-care-testing reliably detects the use of non-steroidal anti-inflammatory drugs that may worsen bleeding and reduce platelet activity, particularly in patients with intracerebral hemorrhage. How best to monitor the effect of platelet transfusion or platelet-activating therapy is not well studied. For patients known to take novel oral anticoagulants, drug-specific coagulation tests before neurosurgical intervention are prudent.

Original languageEnglish (US)
Pages (from-to)168-176
Number of pages9
JournalNeurocritical Care
Issue number2
StatePublished - Oct 1 2014


  • Anemia
  • Coagulation
  • Platelet
  • Platelet function assay
  • Point-of-care test
  • Thrombosis
  • Transfusion

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Clinical Neurology


Dive into the research topics of 'Monitoring of Hematological and Hemostatic Parameters in Neurocritical Care Patients'. Together they form a unique fingerprint.

Cite this